Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
EGFR S492R
i
Other names:
EGFR, ERBB, ERBB1, Epidermal growth factor receptor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
1956
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
›
Associations
(4)
News
Trials
Phase
Status
Apply
Phase
Status
Apply
Panitumumab With or Without Trametinib in Treating Patients With Stage IV Colorectal Cancer (NCT03087071)
Phase 2
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Active, not recruiting
Phase 2
M.D. Anderson Cancer Center
Active, not recruiting
Last update posted :
12/21/2023
Initiation :
12/29/2017
Primary completion :
01/31/2025
Completion :
01/31/2025
KRAS • BRAF • NRAS • MAP2K1
|
KRAS mutation • BRAF mutation • NRAS mutation • KRAS wild-type • RAS wild-type • NRAS wild-type • KRAS exon 2 mutation • EGFR S492R • KRAS exon 2 wild-type
|
Mekinist (trametinib) • Vectibix (panitumumab)
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login